Lumida
/NXXT
⌘K
NextNRG Inc

NextNRG Inc

NXXT
$0.15USD↓-4.89%-0.01 today

MARKET CAP

24.5M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$0 – $0

52W RANGE

$0
$3

AI Summary

Stalk
Sell NowHigh

NXXT remains in a Stage 4 decline characterized by sequential lower highs and lower lows. The medium-term bias is bearish, reinforced by a prominent Lower Highs & Lower Lows pattern and failing rallies at downward-sloping EMAs. Short-term execution favors selling now as price trades below the 9EMA, 20EMA, and 50SMA with continued downside momentum. Execution should occur on rejection into that EMA resistance zone, while being mindful that oversold conditions could produce a temporary relief bounce.

  • ↑Q2 2026 revenue grew 40.9% YoY to $27.7M, boosting top-line momentum
  • ↑Secured $3.5M revenue commitment via a 25-year microgrid deal with Taft Medical
  • ↓Negative profitability metrics highlight inability to generate sustainable profits
Full analysis →

Buying

3

institutions

Selling

3

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
CA

Citadel Advisors LLC

Q2 2026

BUY6.10 M2.14 M+6.08 M+28371.7%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL384.04 K134.49 K+-391.75 K-56.7%0.00%
MM

Millennium Management LLC

Q2 2026

BUYNEW346.73 K121.42 K+346.73 K+0.0%0.00%
BI

Blackrock, Inc.

Q2 2026

SELL94.95 K33.25 K+-1.71 M-95.4%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUYNEW30.19 K10.57 K+30.19 K+0.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL0.000.00+-61.21 K-100.0%0.00%